Literature DB >> 15826430

Hepatitis C and general practice: the crucial role of primary care in stemming the epidemic.

John Budd, Roy Robertson.   

Abstract

Mesh：

Year:  2005        PMID： 15826430      PMCID： PMC1463125     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  13 in total

1.  Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

Authors:  T Poynard; V Ratziu; F Charlotte; Z Goodman; J McHutchison; J Albrecht
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

2.  Sexual transmission of hepatitis C virus.

Authors:  D Bresters; E P Mauser-Bunschoten; H W Reesink; G Roosendaal; C L van der Poel; R A Chamuleau; P L Jansen; C J Weegink; H T Cuypers; P N Lelie
Journal:  Lancet       Date:  1993-07-24       Impact factor: 79.321

3.  Treatment of acute hepatitis C with interferon alfa-2b.

Authors:  E Jaeckel; M Cornberg; H Wedemeyer; T Santantonio; J Mayer; M Zankel; G Pastore; M Dietrich; C Trautwein; M P Manns
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

4.  Cost effectiveness of combination therapy for hepatitis C: a decision analytic model.

Authors:  K Stein; W Rosenberg; J Wong
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

5.  Impact of a positive hepatitis C diagnosis on homeless injecting drug users: a qualitative study.

Authors:  Charlotte Ne Tompkins; Nat Mj Wright; Lesley Jones
Journal:  Br J Gen Pract       Date:  2005-04       Impact factor: 5.386

6.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

7.  Estimating progression to cirrhosis in chronic hepatitis C virus infection.

Authors:  A J Freeman; G J Dore; M G Law; M Thorpe; J Von Overbeck; A R Lloyd; G Marinos; J M Kaldor
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

8.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

9.  Changing patterns in causes of death in a cohort of injecting drug users, 1980-2001.

Authors:  Lorraine Copeland; John Budd; J Roy Robertson; Rob A Elton
Journal:  Arch Intern Med       Date:  2004-06-14

Review 10.  Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.

Authors:  B J Veldt; G Saracco; N Boyer; C Cammà; A Bellobuono; U Hopf; I Castillo; O Weiland; F Nevens; B E Hansen; S W Schalm
Journal:  Gut       Date:  2004-10       Impact factor: 23.059
View more
  6 in total

Review 1.  Can antiviral treatment for hepatitis C be safely and effectively delivered in primary care?: a narrative systematic review of the evidence base.

Authors:  Iain F Brew; Christine Butt; Nat Wright
Journal:  Br J Gen Pract       Date:  2013-12       Impact factor: 5.386

2.  Hepatitis C infection among injecting drug users in general practice: a cluster randomised controlled trial of clinical guidelines' implementation.

Authors:  Walter Cullen; June Stanley; Deirdre Langton; Yvonne Kelly; Anthony Staines; Gerard Bury
Journal:  Br J Gen Pract       Date:  2006-11       Impact factor: 5.386

3.  Knowledge of hepatitis B and vaccination status of some expatriate ethnic groups of blue collar workers in northern saudi arabia.

Authors:  Abdul Satter Khan; Maisa Al-Sweilem; Zekeriya Akturk
Journal:  J Family Community Med       Date:  2008-05

4.  Chronic illness and multimorbidity among problem drug users: a comparative cross sectional pilot study in primary care.

Authors:  Walter Cullen; Sarah O'Brien; Austin O'Carroll; Fergus D O'Kelly; Gerard Bury
Journal:  BMC Fam Pract       Date:  2009-04-21       Impact factor: 2.497

5.  Prevalence of problem alcohol use among patients attending primary care for methadone treatment.

Authors:  Niamh Ryder; Walter Cullen; Joseph Barry; Gerard Bury; Eamon Keenan; Bobby P Smyth
Journal:  BMC Fam Pract       Date:  2009-06-11       Impact factor: 2.497

6.  Increasing uptake of hepatitis C virus infection case-finding, testing, and treatment in primary care: evaluation of the HepCATT (Hepatitis C Assessment Through to Treatment) trial.

Authors:  Jeremy Horwood; Clare Clement; Kirsty Roberts; Cherry-Ann Waldron; William L Irving; John Macleod; Mathew Hickman
Journal:  Br J Gen Pract       Date:  2020-07-30       Impact factor: 5.386
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.